Eli Lilly to cap out of pocket price of insulin at $35
The price cap will be consistent with the Biden administration's Inflation Reduction Act.
Stay updated with breaking news from Davida Ricks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The price cap will be consistent with the Biden administration's Inflation Reduction Act.
The pharmaceutical company Eli Lilly and Company announced it would lower the price of its most prescribed insulins by 70 per cent and cap out-of-pocket costs for people at $35 per month
Eli Lilly & Co. is capping out-of-pocket costs for insulin at $35 a month, following a public plea from President Joe Biden for lower prices of the diabetes treatment for all Americans.
Some lawmakers have pushed for insulin prices to be capped. Eli Lilly said on Wednesday it will do so voluntarily.
Eli Lilly & Co. is capping out-of-pocket costs for insulin at $35 a month, following a public plea from President Joe Biden for lower prices of the diabetes treatment for all Americans. Lilly anno...